Vicapsys Life Sciences, Inc. (VICP) stock
VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)
Close on Oct 19, 2026Market cap $13.73MP/E –Yield –
Vicapsys Life Sciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Vicapsys Life Sciences's total debt was $12.55K at Jun 30, 2024. For fiscal 2023 it was $18.71K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $18.71K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | $12.55K | -76.9% |
| Q1 FY2024 | Mar 31, 2024 | $12.55K | – |
| Q4 FY2023 | Dec 31, 2023 | $18.71K | – |
| Q3 FY2023 | Sep 30, 2023 | $36.79K | – |
| Q2 FY2023 | Jun 30, 2023 | $54.23K | – |
See a number that looks wrong?